RHÃ?N-KLINIKUM AG 31.10.2013 13:00 Dissemination of a Voting Rights Announcement, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Notification according to section 26 para. 1 WpHG Morgan Stanley & Co. LLC, Wilmington/Delaware, USA, Morgan Stanley Domestic Holdings Inc., Wilmington/Delaware, USA, Morgan Stanley Capital Management LLC, Wilmington/Delaware, USA and Morgan Stanley, Wilmington/Delaware, USA notified us pursuant to section 21 para. 1 WpHG of the following: 1) On 25 October 2013, Morgan Stanley & Co. LLC exceeded the threshold of 3% of the voting rights in RHÃ?N-KLINIKUM AG, Salzburger Leite 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, Morgan Stanley & Co. LLC held 3.25% of the voting rights in RHÃ?N-KLINIKUM AG arising from 4,497,820 voting rights. Of these voting rights, a proportion of 0.04% (equals 52,700 voting rights) is attributed to Morgan Stanley & Co. LLC pursuant to section 22 para. 1 sent. 1 no. 1 WpHG. 2) On 25 October 2013, Morgan Stanley Domestic Holdings Inc. exceeded the threshold of 3% of the voting rights in RHÃ?N-KLINIKUM AG, Salzburger Leite 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, Morgan Stanley Domestic Holdings Inc. held 3.25% of the voting rights in RHÃ?N-KLINIKUM AG arising from 4,497,820 voting rights. Of these voting rights, a proportion of 3.25% (equals 4.497.820 voting rights) is attributed to Morgan Stanley Domestic Holdings Inc. pursuant to section 22 para. 1 sent. 1 no. 1 WpHG (name of controlled undertaking: Morgan Stanley & Co. LLC). 3) On 25 October 2013, Morgan Stanley Capital Management LLC exceeded the threshold of 3% of the voting rights in RHÃ?N-KLINIKUM AG, Salzburger Leite 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, Morgan Stanley Capital Management LLC held 3.25% of the voting rights in RHÃ?N-KLINIKUM AG arising from 4,497,820 voting rights. Of these voting rights, a proportion of 3.25% (equals 4,497,820 voting rights) is attributed to Morgan Stanley Capital Management LLC pursuant to section 22 para. 1 sent. 1 no. 1 WpHG (names of controlled undertakings: Morgan Stanley & Co. LLC; Morgan Stanley Domestic Holdings Inc.). 4) On 25 Oktober 2013, Morgan Stanley exceeded the threshold of 3% of the voting rights in RHÃ?N-KLINIKUM AG, Salzburger Leite 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, Morgan Stanley held 3.25% of the voting rights in RHÃ?N-KLINIKUM AG arising from 4,497,820 voting rights. Of these voting rights, a proportion of 3.25% (equals 4,497,820 voting rights) is attributed to Morgan Stanley pursuant to section 22 para. 1 sent. 1 no. 1 WpHG (names of controlled undertakings: Morgan Stanley & Co. LLC; Morgan Stanley Domestic Holdings Inc.; Morgan Stanley Capital Management LLC). Bad Neustadt a.d. Saale, 31 October 2013 The Board of Management ________________________________________________________________ Dr. Kai G. Klinger Head of Investor Relations RHÃ?N-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a. d. Saale Phone: +49 9771 65 - 1318 Fax: +49 9771 99 - 1736 31.10.2013 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: RHÃ?N-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a.d.Saale Germany Internet: www.rhoen-klinikum-ag.com End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-PVR: RHÃ?N-KLINIKUM AG: Release according to Article
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Innovative Veterinary Software Enhancements by Weave Simplified
Weave Enhancements Tailored for Veterinary Practices Weave, a prominent player in the customer experience and payments software arena, has recently made significant improvements aimed specifically at veterinary clinics. The updates are the result of thorough feedback from veterinary professionals, designed to enhance operational workflows and significantly improve client...
Continue Reading
Recursion Pharmaceuticals Earnings: What Investors Should Know
Eyes on the Earnings: Recursion Pharmaceuticals’ Upcoming Report The air is thick with anticipation as Recursion Pharmaceuticals (NASDAQ: RXRX) prepares to unveil its latest quarterly earnings this coming Wednesday, February 25, 2026. Investors are itching to dissect every line of the release for tidbits that could shape their strategies moving forward. EPS...
Continue Reading
Middlefield Banc Corp's CEO Invests $6K, Reflecting Confidence
Middlefield Banc Corp's CEO Makes a Notable Stock Purchase Recently, Ronald Len Zimmerly Jr., the CEO of Middlefield Banc Corp (NASDAQ: MBCN), drew attention by boosting his investment in the company. He bought shares worth approximately $6,000, acquiring 212.283 shares at a price of $28.47 each. After this transaction, Zimmerly now holds a total of 31,289.283 shares of...
Continue Reading
Exploring Sandbox VR's Exciting New Franchise Partnership
Sandbox VR Expands Its Franchise Network Sandbox VR, the leader in premium location-based virtual reality experiences, is set to grow its horizons by partnering with LOL Entertainment. This exciting collaboration aims to introduce Sandbox VR locations in several prominent East Coast cities, enhancing the entertainment scene with innovative virtual reality experiences. New...
Continue Reading
Investors May Engage in Semler Scientific, Inc. Lawsuit
Understanding the Semler Scientific, Inc. Lawsuit Investors have been alerted of an upcoming class action lawsuit against Semler Scientific, Inc. regarding allegations of securities fraud. The law firm spearheading this action, The Schall Law Firm, is committed to representing those who have been affected and encouraging participation from shareholders. What Are the...
Continue Reading